Prolyl hydroxylase PHD3 enhances the hypoxic survival and G1 to S transition of carcinoma cells.

Abstract

Hypoxia restricts cell proliferation and cell cycle progression at the G1/S interface but at least a subpopulation of carcinoma cells can escape the restriction. In carcinoma hypoxia may in fact select for cells with enhanced hypoxic survival and increased aggressiveness. The cellular oxygen sensors HIF proline hydroxylases (PHDs) adapt the cellular functions to lowered environmental oxygen tension. PHD3 isoform has shown the strongest hypoxic upregulation among the family members. We detected a strong PHD3 mRNA expression in tumors of head and neck squamous cell carcinoma (HNSCC). The PHD3 expression associated with expression of hypoxic marker gene. Using siRNA in cell lines derived from HNSCC we show that specific inhibition of PHD3 expression in carcinoma cells caused reduced cell survival in hypoxia. The loss of PHD3, but not that of PHD2, led to marked cell number reduction. Although caspase-3 was activated at early hypoxia no induction of apoptosis was detected. However, hypoxic PHD3 inhibition caused a block in cell cycle progression. Cell population in G1 phase was increased and the population in S phase reduced demonstrating a block in G1 to S transition under PHD3 inhibition. In line with this, the level of hyperphosphorylated retinoblastoma protein Rb was reduced by PHD3 knock-down in hypoxia. PHD3 loss led to increase in cyclin-dependent kinase inhibitor p27 expression but not that of p21 or p16. The data demonstrated that increased PHD3 expression under hypoxia enhances cell cycle progression and survival of carcinoma cells.

• Authors: Heidi Högel, Krista Rantanen, Terhi Jokilehto, Reidar Grenman, Panu M Jaakkola
• Journal: PloS one (PLoS One) Vol. 6 Issue 11 Pg. e27112 ( 2011) ISSN: 1932-6203 [Electronic] United States
• PMID: 22087251 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)

Chemical References

• RNA, Small Interfering
• Dioxygenases
• EGLN1 protein, human
• Procollagen-Proline Dioxygenase
• EGLN3 protein, human
• Hypoxia-Inducible Factor-Proline Dioxygenases

Topics

• Carcinoma, Squamous Cell (drug therapy, pathology)
• Cell Line, Tumor
• Cell Survival (drug effects)
• Dioxygenases (antagonists & inhibitors, genetics, physiology)
• G1 Phase (drug effects)
• Head and Neck Neoplasms (drug therapy, pathology)
• Humans
• Hypoxia (genetics)
• Hypoxia-Inducible Factor-Proline Dioxygenases
• Procollagen-Proline Dioxygenase (genetics, physiology)
• RNA, Small Interfering (pharmacology)
• S Phase (drug effects)
• Squamous Cell Carcinoma of Head and Neck